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Arteriovenous malformations (AVMs) are considered congenital lesions of the brain. They are however diagnosed mainly in patients at their 30s or 40s, whereas the incidence in children is lower. Angiogenic potential of AVMs in children can be responsible for systematic growth of the lesions during childhood and adolescence and is proposed to be one of the reasons of relatively low number of lesions diagnosed at young age \[[@CR17], [@CR23], [@CR37]\]. The intensity of angiogenesis seems to decrease over time and probably is negligible in the mature organism. There is however some evidence that certain factors, like the material used for embolization or transient hypoxia caused by the procedure itself, can stimulate angiogenesis in otherwise mature AVMs \[[@CR2], [@CR39]\].

There is still a widespread opinion that the mainstay of the treatment is microneurosurgical removal of the AVM. There is however an increasing number of evidence that stereotactic radiosurgery can be considered as a primary treatment modality in children and the number of treatment-related complications can be even lower than in adults \[[@CR30]\]. Usually, the lesions that cannot be surgically removed are treated with embolization or stereotactic radiosurgery often associated with endovascular procedures \[[@CR24]\]. Embolization in certain cases however may result with subtotal occlusion of the nidus leaving some portions of the lesion connected to the circulation and thus, posing a risk of rupture \[[@CR26], [@CR35]\]. Nevertheless, curative embolization can be attempted with good results in carefully selected patients with small- or intermediate-sized AVMs \[[@CR42]\].

The treatment of arteriovenous malformations in children is a special challenge. Not only due to angioproliferative potential of the lesion which can attenuate the results of the treatment but also due to higher risk of bleeding than in adults, substantial death rate, and potential late sequelae of the treatment \[[@CR22], [@CR28], [@CR43]\]. There are also concerns that exposure of the immature brain to ionizing radiation can affect the intellectual abilities or cause neurological damage \[[@CR43]\]. Moreover, AVMs in children are more often localized in deep structures or eloquent regions of the brain than in adults which makes the surgical treatment more difficult or even impossible.

Discussing the indications for radiosurgery of AVMs in children, it is important to note that death rate due to cerebral hemorrhages in children is very high and ranges between 6 and 38 % according to various sources \[[@CR4], [@CR6], [@CR40]\]. AVM rupture is one of the most frequent reasons of hemorrhagic stroke in children and is responsible for 14--56 % of all strokes in this age group \[[@CR4], [@CR6], [@CR10], [@CR12], [@CR16], [@CR40]\]. Cumulative risk of bleeding from an AVM can be calculated from the Brown formula and is directly associated with age of the patient \[[@CR7]\]. It means that AVM diagnosed in a child almost inevitably leads to and intracranial hemorrhage (ICH), and thus, should be treated. The available choices are microneurosurgery, stereotactic radiosurgery, and embolization. Sometimes satisfactory results can be obtained only with a combination of two or even three methods.

In this report, we review our experience with linear accelerator-based radiosurgical treatment of pediatric AVMs. We focus on obliteration rate, prevention of intracranial hemorrhage, side effects of the treatment, and radiation-induced alterations in imaging studies.

Material and methods {#Sec2}
====================

A group of ten consecutive children (four boys and six girls) irradiated between 2002 and 2010 at our institution is analyzed in the current study. The mean age at the time of treatment was 15.4 and ranged between 8 and 18 years. There were two Spetzler--Martin grade IV, four grade III, and four grade II lesions. The mean AVM volume was 13.2 cm^3^ and ranged between 0.5 and 36.8 cm^3^. For all lesions, the modified radiosurgery-based AVM score defined as AVM score = 0.1 × AVM volume + 0.02 × patient's age + 0.3 × location (location is a two-tiered variable and has a value of 1 for lesions located in thalamus, basal ganglia, and brainstem; for other locations, the value is 0) was calculated \[[@CR33]\]. The mean and median modified radiosurgery-based AVM score was 1.69 and 1.7, respectively, and ranged between 0.41 and 4.26. All AVMs were located supratentorially, three of them intra- or periventricularly. Six patients presented with hemorrhage, three with epileptic seizures, and one only with impaired consciousness. One patient had bled twice before the treatment was started. Two had symptoms of hemiparesis after ICH. One patient underwent a surgical procedure (subtotal removal of the nidus) before irradiation. We decided to include in this report patients treated both with stereotactic radiosurgery and hypofractionated stereotactic radiotherapy because of low number of children irradiated for cerebral AVMs and in order to allow direct comparison of the two fractionation regimens. The clinical and treatment characteristics of each patient are presented in detail in Table [1](#Tab1){ref-type="table"} in order to facilitate potential future meta-analysis of the results of stereotactic irradiation of pediatric AVMs.Table 1Individual characteristics of the patients and outcomeSexAge at diagnosisAge at SRS/HFSRTPresenting symptomsSpetzler--Martin gradeAVM scoreVolume (cm^3^)Total dose (Gy)Number of fractionsObliterationImaging abnormalitiesHeadachesVisual disturbancesSeizuresLoss of consciousnessParesisNumber of hemorrhagesF1414YesNoNoYesYes144.2636.81162No0M1617NoNoYesYesNo021.3610.25181T1F88NoNoYesYesNo030.543.8216 + 15^a^1 + 1^a^T1F1213YesNoNoYesYes130.684.24201T1F1718NoNoNoYesNo032.5919.36213T1M1515NoYesYesNoNo021.8915.94213T0M1718YesNoNoNoNo120.410.56181P1M1718YesNoNoNoNo121.7914.33222T0F1618YesNoNoNoNo231.6112.52181T1F1415YesNoNoNoNo142.0514.59243T0*M* male, *F* female, *T* total obliteration, *P* partial obliteration, *SRS* stereotactic radiosurgery, *HFSRT* hypofractionated stereotactic radiotherapy^a^Doses and number of fractions of two separate procedures

All patients were irradiated with a linear accelerator with a micro-multileaf collimator used for field shaping. The head was immobilized in a thermoplastic mask designed for stereotactic treatment and a relocatable stereotactic frame was used in all cases to define external coordinates. Treatment planning was based on computed tomography performed with the relocatable stereotactic frame, magnetic resonance (MR), and magnetic resonance angiography images. In no case anesthesia was required. The dose was specified at the isocenter and the planning was optimized to encompass the lesion with 95 % isodose. In case of lesions adjacent to organs at risk, like the optic pathway or brainstem, a focal drop to 90 % of the prescribed dose was accepted. In five patients, the planned dose of 16--20 Gy was delivered in a single fraction, in five the total dose of 16--24 Gy was delivered in two to three fractions. One patient was reirradiated with a dose of 15 Gy, 7 years after the initial treatment. Apart from the use of stereotactic frame, the correct position of the patient was additionally verified with the on-board imaging device immediately before irradiation to account for possible positioning inaccuracies that may occur when stereotactic mask and relocatable frame are used instead for invasively fixated stereotactic frame. Actuarial obliteration rates were calculated with Kaplan--Meier method. Due to small number of patients in our series, subgroup comparisons were made with Fisher's exact test for small samples.

Results {#Sec3}
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The median follow-up time was 38.5 months and ranged from 13 to 120 months. The treatment resulted in total obliteration in eight patients and partial in one; in one, no response to treatment was seen. One patient was irradiated twice because of incomplete obliteration after the first procedure. The second treatment was performed 7 years after the first irradiation and resulted with total obliteration of the nidus. The median time to obliteration was 22 months. Crude total obliteration rate was 80 %. Actuarial total obliteration rates were 20, 54, 54, and 83 % after 1, 2, 3, and 4 years of follow-up, respectively. Crude response rate (total and partial obliterations) was 90 %. Actuarial treatment response rates were 20, 54, 65, and 89 % after 1, 2, 3, and 4 years of follow-up, respectively. The only patient who did not respond to the treatment had the largest lesion (36.8 cm^3^) and was irradiated with 16 Gy delivered in two fractions because of the size of the nidus and critical location, adjacent to the brainstem and optic pathway. In this patient, reirradiation of the nidus is considered.

No patient bled during 42.5 patient-years of observation; therefore, bleeding risk after treatment could not be reliably calculated. In one patient, new epileptic seizures developed after the treatment. MR imaging revealed symptoms of demyelination around the irradiated nidus. The seizures gradually resolve and currently she experiences only an aura in approximately every 6 months. In one patient, after the second treatment, an asymptomatic focal necrosis was revealed on MRI which partially resolved after another year of follow-up.

In five patients, asymptomatic imaging abnormalities were seen during follow-up. The imaging abnormalities were defined as T2 or FLAIR hyperintensity or T1 hypointense areas. Due to low number of patients in the study, no detailed statistical calculations could be made. According to results of the Fisher's exact test, no apparent dependence of obliteration on AVM volume, Spetzler--Martin grade (2 vs. \>2), dose (\<20 vs. ≥20 Gy), or AVM score (\<1.7 (median value) vs. ≥1.7) could be identified. Both single fraction treatment and hypofractionated stereotactic radiotherapy resulted with comparable number of obliterations (*p* = 0.33 and *p* = 0.6 for total and total + partial obliterations, respectively, Fisher's exact test). Similarly, no apparent association of the dose, fractionation regimen, and volume irradiated and the incidence of imaging abnormalities could be seen.

Discussion {#Sec4}
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This is a series of ten children irradiated for cerebral AVMs with crude obliteration rate of 80 % and no bleeding observed after the treatment. Hemorrhage form a ruptured AVM is the most frequent symptom leading to the diagnosis of the malformation both in adults and children \[[@CR19]\]. Nevertheless, both death rate and the risk of permanent neurological sequelae are higher in children \[[@CR5], [@CR9]\]. These data show that the potential risk associated with exposition of the immature organism for ionizing radiation is overcome by expected elimination of the risk of bleeding. In our series, no bleeding occurred after the treatment which is in line with the results reported by Nicolato et al. and compares favorably with other series reporting the annual bleeding hazard rate of 1.3--4.7 %, to even 9.1 % in the first and 13.6 % in the second year of follow-up \[[@CR8], [@CR22], [@CR29], [@CR31], [@CR44]\]. According to the literature, malformations in the posterior fossa are of special concern because the risk of death following rupture can approach 42--57 % and that location is much more frequent in children than in adults \[[@CR15], [@CR21], [@CR27], [@CR34]\]. In our series, no lesion was localized in the infratentorial space. It can be explained by selection bias resulting from relative low number of children referred to radiosurgery for AVMs in our country and limited number of patients included into the study.

Crude total obliteration rate of 80 % in our series is among the highest of reported by other authors \[[@CR8], [@CR18], [@CR22], [@CR31], [@CR32], [@CR36], [@CR44]\]. Better results can be obtained by applying higher doses but this carries a risk of increasing the complication rate. Doses of 24--25 Gy specified on the surface of the lesion allow for obliteration rate approaching 100 % but at the cost of unacceptable risk of serious complications. In the series published by Mirza et al., the incidence of adverse effects after delivery of 24--25 Gy in single fraction was as high as 50 % \[[@CR28]\]. Actuarial obliteration rate was stable in the second and third year of follow-up; this phenomenon however can be explained as a statistical artifact resulting from low number of patients in our series.

Total obliteration is considered the ultimate goal of radiosurgery for cerebral AVMs. Nevertheless, literature data indicate that subtotally obliterated malformations possess a negligible risk of bleeding and eventually obliterate in most cases \[[@CR22]\]. In our opinion, the primary goal of radiosurgery should be elimination of the risk of bleeding but not necessarily complete obliteration without early draining veins on angiography. Pertinent aiming at complete radiological obliteration by application of higher doses increases the risk associated with the treatment without apparent profits for the patient because the risk of hemorrhage is not further reduced in a significant way \[[@CR1], [@CR22]\].

The probability of obliteration was not directly associated with the fractionation regimen. Both single fraction treatment and hypofractionated stereotactic radiotherapy yielded comparable rates of obliterations. Satisfactory results of hypofractionation in children could be associated with biological features of an immature AVM. Higher mitotic and metabolic activity of the cells can possibly result with faster and more efficient production of myofibroblasts responsible for subsequent obliteration of the nidus. This can be true even after stimulation with lower single doses, assuming that fraction dose is sufficient for triggering the effect and total dose applied is within the therapeutic range. There is some evidence that younger patients respond better to radiosurgery, not only when comparing children and adult population, but even if we consider only the group of pediatric patients \[[@CR31], [@CR34], [@CR36]\]. The difference in biological features between adult and pediatric AVMs was already proposed in the literature and confirmed in recent studies, but the exact reason of the specific behavior of the pediatric AVMs is still to be explained \[[@CR25], [@CR31]\]. Vascular proliferation and expression of VEGF and its receptors observed in AVMs, de novo formation of the lesions, and low prevalence of AVMs in infants suggest that these lesions in young age can have greater mitotic potential resulting with greater alpha/beta ratio than that reported in the adult population \[[@CR3], [@CR11], [@CR13], [@CR17], [@CR23], [@CR38], [@CR39]\]. Estimations of alpha/beta ratio for AVMs yielded the value of 1.2--3.5 Gy, characteristic for non-proliferating, late responding tissues \[[@CR20]\]. Analysis of smaller lesions however suggested that they can respond somewhat different and the alpha/beta ratio can approach 5--6 Gy which can be the rationale for hypofractionated regimens \[[@CR20]\]. If pediatric AVMs present similar propensities, higher obliteration rates than in adults after hypofractionated stereotactic radiotherapy can be expected. This hypothesis of course is of very speculative nature and its confirmation requires specific studies.

The incidence of imaging abnormalities after the treatment is relatively high in our series. Most authors report imaging abnormalities in about one third of the patients after treatment \[[@CR22], [@CR41], [@CR42]\]. In a series reported by Hayhurst et al., it was approaching 50 % of the patients, Nataf et al. reported even higher rate of parenchymal changes (44.8 % with T2 hyperintensity, 55.1 % including T1 enhancement and necrosis) \[[@CR14], [@CR29]\]. In our study, the incidence was 60 % including one asymptomatic radiation necrosis. The doses applied were within the range reported in other series and did not appear to be the reason of frequent occurrence of imaging alterations. Most publications describe experiences with gamma knife treatment with dose usually specified on the 50 % isodose. It means that maximal doses that could be responsible for initiation of radiation damage in the brain are twice as high as the prescribed ones. Utilization of a linear accelerator for treatment allows delivery of more homogeneous dose than in case of gamma knife, without hot spots characteristic for the latter and which theoretically could reduce the risk of radiation-induced damage. Our observations however do not support this assumption. The occurrence of imaging abnormalities also did not appear to be associated with the volume treated. In other studies, the irradiated volume was considered to be the main risk factor for subsequent imaging alterations \[[@CR14]\]. Low number of patients treated precludes the possibility of identification of risk factors for radiation-induced imaging abnormalities. On the other hand, high signal intensity on post-treatment T2 MR images can be related to higher chance of obliteration \[[@CR41]\]. High incidence of imaging alterations along with high obliteration rate in the current study could support this assumption. Late adverse effects of the treatment were not observed in our series. The occurrence of imaging alterations according to Yeon et al. was not associated with increased risk of neuropsychological sequelae \[[@CR43]\]. The results of stereotactic irradiation of a large series of patients shown by Nicolato et al. confirm the safety of this kind of treatment as no adverse neuropsychological effects or intellectual deterioration were observed in this group of patients which is an argument in favor of noninvasive treatment of cerebral AVMs in children with stereotactic radiosurgery \[[@CR30]\]. Nevertheless, the potential risk of decreased neurocognitive abilities after stereotactic irradiation, especially in children, should not be neglected. Consequently, relative high incidence of the imaging alterations in our opinion is the argument for long-term and meticulous observation after the treatment.

Conclusions {#Sec5}
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Due to small number of patients in our series, we do not attempt to draw general conclusions. It can be assumed that stereotactic radiosurgery is an effective method of treatment for pediatric AVMs. The patients require meticulous follow-up because of relative high incidence of radiation-induced imaging and potential risk of late adverse effects of the treatment. Further studies aiming at elucidation of radiobiological properties of AVMs in pediatric population are needed in order to establish the most efficient and safe fractionation regimen. Detailed analysis of the dose--response relationship on data pooled from other centers would probably shed more light on the actual alpha/beta ratio of pediatric AVMs and perhaps would allow for optimization of the treatment protocols.
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